HIQBIOT
Index Performance
+9.75%
HIQBIOT
+11.40%
TMLARGE
+5.24%
DIA
This index is hidden.
Visit your dashboard to unhide.
Overview
Description
Biotech
- TickerHIQBIOT
- Inception Date12/03/2023
- WeightingSq. Root Market Cap
- # of holdings144
What's inside?
Holdings
All holdings as of July 23, 2024
CSV download
| Amgen, Inc. (AMGN) | 4.30% | $179.33B | 22.19% | 56.73% | 7.04 |
| Danaher Corp. (DHR) | 3.98% | $195.06B | -19.76% | 59.69% | 8.11 |
| Vertex Pharmaceuticals, Inc. (VRTX) | 3.43% | $127.03B | 14.21% | 87.25% | 9.80 |
| Regeneron Pharmaceuticals, Inc. (REGN) | 3.14% | $115.32B | -0.54% | 82.58% | 7.86 |
| CSL Ltd. (CSL) | 3.02% | $96.92B | 35.36% | N/A | 7.83 |
| Gilead Sciences, Inc. (GILD) | 2.68% | $95.32B | 5.66% | 76.79% | 4.03 |
| Moderna, Inc. (MRNA) | 2.13% | $46.14B | -91.07% | 20.96% | 6.49 |
| Lonza Group AG (LONN) | 1.97% | $45.64B | 7.94% | 27.04% | 4.11 |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 1.92% | $30.09B | 54.82% | 86.65% | 9.57 |
| IQVIA Holdings, Inc. (IQV) | 1.80% | $42.35B | 2.53% | 27.71% | 3.35 |
| argenx SE (ARGX) | 1.63% | $28.79B | 198.86% | 81.59% | 15.14 |
| Biogen, Inc. (BIIB) | 1.61% | $33.11B | -5.62% | 68.65% | 4.02 |
| Insmed, Inc. (INSM) | 1.53% | $12.01B | 15.77% | 75.21% | 15.22 |
| ICON plc (ICLR) | 1.46% | $25.89B | 4.95% | 22.49% | 3.51 |
| Novozymes A/S (NZYM.B) | 1.44% | $17.32B | 1.97% | 52.03% | 6.15 |
| United Therapeutics Corp. (UTHR) | 1.36% | $14.92B | 33.70% | 89.24% | 3.73 |
| Sandoz Group AG (SDZ) | 1.27% | $13.67B | 0.74% | N/A | N/A |
| BioNTech SE (BNTX) | 1.26% | $20.13B | -85.14% | 68.50% | 4.32 |
| Sarepta Therapeutics, Inc. (SRPT) | 1.16% | $13.95B | 63.10% | 85.66% | 9.14 |
| Incyte Corp. (INCY) | 1.13% | $15.42B | 8.93% | 91.24% | 2.42 |
| BeiGene Ltd. (688235) | 1.12% | $17.70B | 76.35% | 80.17% | 8.40 |
| Neurocrine Biosciences, Inc. (NBIX) | 1.11% | $14.70B | 22.57% | 97.52% | 6.87 |
| Revolution Medicines, Inc. (RVMD) | 0.98% | $7.52B | -100.00% | N/A | 808.96 |
| Bio-Techne Corp. (TECH) | 0.98% | $12.40B | 3.16% | 67.64% | 10.09 |
| Avantor, Inc. (AVTR) | 0.98% | $15.50B | -5.65% | 33.96% | 3.28 |
| Kyowa Kirin Co., Ltd. (4151) | 0.95% | $10.85B | 12.87% | 72.94% | 2.49 |
| bioMérieux SA (BIM) | 0.94% | $12.42B | 2.38% | 54.87% | 3.30 |
| Sartorius Stedim Biotech SA (DIM) | 0.93% | $17.35B | 4.54% | 43.36% | 6.34 |
| Catalent, Inc. (CTLT) | 0.92% | $10.58B | 3.57% | 21.32% | 3.64 |
| Vaxcyte, Inc. (PCVX) | 0.92% | $9.10B | N/A | N/A | N/A |
| Charles River Laboratories International, Inc. (CRL) | 0.88% | $11.43B | -1.73% | 31.65% | 4.10 |
| WuXi AppTec Co., Ltd. (603259) | 0.87% | $15.15B | 2.27% | 39.99% | 5.18 |
| Blueprint Medicines Corp. (BPMC) | 0.87% | $7.12B | 51.87% | 91.68% | 21.27 |
| Halozyme Therapeutics, Inc. (HALO) | 0.87% | $7.12B | 20.81% | 76.47% | 7.31 |
| Intra-Cellular Therapies, Inc. (ITCI) | 0.86% | $8.53B | 52.00% | 93.17% | 12.15 |
| Roivant Sciences Ltd. (ROIV) | 0.83% | $7.93B | 103.65% | 77.59% | 25.63 |
| Shanghai RAAS Blood Products Co., Ltd. (002252) | 0.76% | $7.11B | -0.51% | 39.26% | 5.30 |
| Grifols SA (GRF) | 0.76% | $6.18B | 8.71% | 35.24% | 3.37 |
| Ascendis Pharma A/S (ASND) | 0.76% | $7.75B | 188.79% | 88.27% | 25.21 |
| Beijing Tiantan Biological Products Corp. Ltd. (600161) | 0.76% | $6.73B | 17.04% | N/A | N/A |
| DiaSorin SpA (DIA) | 0.74% | $6.16B | -15.64% | 58.27% | 5.21 |
| Novavax, Inc. (NVAX) | 0.73% | $2.34B | 15.94% | 48.00% | 0.41 |
| Exelixis, Inc. (EXEL) | 0.73% | $6.69B | 4.02% | 95.00% | 3.51 |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 0.71% | $6.04B | N/A | N/A | N/A |
| Bruker Corp. (BRKR) | 0.68% | $9.72B | 5.31% | 49.40% | 4.95 |
| Cytokinetics, Inc. (CYTK) | 0.66% | $6.86B | -81.90% | -179.16% | 1,940.69 |
| Twist Bioscience Corp. (TWST) | 0.65% | $3.35B | 25.13% | 41.01% | 6.41 |
| Crinetics Pharmaceuticals, Inc. (CRNX) | 0.63% | $4.21B | N/A | N/A | N/A |
| Nuvalent, Inc. (NUVL) | 0.62% | $4.73B | N/A | N/A | N/A |
| Imeik Technology Development Co., Ltd. (300896) | 0.61% | $6.83B | 28.12% | 94.52% | 23.21 |
| Axsome Therapeutics, Inc. (AXSM) | 0.61% | $4.08B | -20.70% | 89.16% | 14.50 |
| BridgeBio Pharma, Inc. (BBIO) | 0.60% | $5.00B | 11,461.88% | 99.10% | 30.87 |
| Morphic Holding, Inc. (MORF) | 0.59% | $2.84B | N/A | N/A | N/A |
| SK Biopharmaceuticals Co., Ltd. (326030) | 0.59% | $4.76B | 87.51% | 86.72% | 17.47 |
| Agios Pharmaceuticals, Inc. (AGIO) | 0.58% | $2.75B | 46.00% | 75.88% | 38.06 |
| Tecan Group AG (TECN) | 0.58% | $4.65B | -6.11% | 33.40% | 4.05 |
| Peptidream, Inc. (4587) | 0.57% | $2.22B | -14.87% | 35.00% | 6.39 |
| ImmunityBio, Inc. (IBRX) | 0.55% | $3.80B | -88.89% | -11,287.50% | 14,367.70 |
| Denali Therapeutics, Inc. (DNLI) | 0.55% | $3.44B | -100.00% | N/A | 7.38 |
| Changchun High-Tech Industry (Group) Co., Ltd. (000661) | 0.54% | $5.07B | 14.51% | 83.30% | 3.06 |
| Merus NV (MRUS) | 0.54% | $3.66B | -41.56% | 92.31% | 59.72 |
| Akeso, Inc. (9926) | 0.54% | $4.32B | 401.75% | 93.91% | 7.31 |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 0.54% | $3.02B | 126.41% | 88.45% | 27.34 |
| Alkermes Plc (ALKS) | 0.53% | $4.74B | -35.35% | 84.24% | 2.40 |
| Immunovant, Inc. (IMVT) | 0.51% | $4.06B | N/A | N/A | N/A |
| Shanghai Junshi Biosciences Co., Ltd. (688180) | 0.51% | $3.39B | 49.13% | 71.19% | 15.80 |
| Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262) | 0.50% | $3.25B | 15.22% | 70.37% | 3.70 |
| Xenon Pharmaceuticals, Inc. (XENE) | 0.50% | $3.31B | N/A | N/A | N/A |
| Arcellx, Inc. (ACLX) | 0.49% | $3.35B | 119.16% | 97.90% | 24.17 |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 0.49% | $3.59B | -100.00% | N/A | 96.25 |
| Vericel Corp. (VCEL) | 0.49% | $2.51B | 25.02% | 68.94% | 11.93 |
| Hualan Biological Engineering, Inc. (002007) | 0.48% | $3.55B | -10.41% | 55.20% | 6.85 |
| Wuxi Biologics (Cayman), Inc. (2269) | 0.48% | $5.67B | 6.01% | 40.08% | 6.66 |
| MorphoSys AG (MOR) | 0.48% | $2.77B | -55.81% | 85.96% | 10.61 |
| IDEAYA Biosciences, Inc. (IDYA) | 0.48% | $3.55B | -100.00% | N/A | 167.65 |
| PTC Therapeutics, Inc. (PTCT) | 0.47% | $2.57B | -4.66% | 68.46% | 1.90 |
| Kymera Therapeutics, Inc. (KYMR) | 0.47% | $2.70B | 8.67% | 85.42% | 30.37 |
| Sinopharm Group Co., Ltd. (1099) | 0.46% | $3.15B | 2.67% | 7.83% | 0.23 |
| Protagonist Therapeutics, Inc. (PTGX) | 0.46% | $2.44B | N/A | 99.68% | 4.82 |
| Emergent BioSolutions, Inc. (EBS) | 0.46% | $723.15M | 81.95% | 46.40% | 0.82 |
| Bavarian Nordic A/S (BAVA) | 0.46% | $2.10B | -33.59% | 31.90% | 1.50 |
| Apellis Pharmaceuticals, Inc. (APLS) | 0.45% | $4.72B | 284.26% | 88.02% | 13.99 |
| Lepu Medical Technology (Beijing) Co., Ltd. (300003) | 0.44% | $2.82B | -21.33% | 66.46% | 3.82 |
| Chongqing Zhifei Biological Products Co., Ltd. (300122) | 0.44% | $5.18B | 2.00% | 25.72% | 2.08 |
| ACADIA Pharmaceuticals, Inc. (ACAD) | 0.43% | $3.06B | 73.75% | 88.85% | 3.28 |
| Amicus Therapeutics, Inc. (FOLD) | 0.43% | $3.04B | 27.97% | 85.76% | 8.91 |
| 3SBio, Inc. (1530) | 0.42% | $1.92B | 8.27% | 84.98% | 2.27 |
| Springworks Therapeutics, Inc. (SWTX) | 0.41% | $2.73B | N/A | 90.81% | 121.00 |
| Rocket Pharmaceuticals, Inc. (RCKT) | 0.40% | $2.35B | N/A | N/A | N/A |
| Asymchem Laboratories (Tianjin) Co., Ltd. (002821) | 0.40% | $3.34B | -39.35% | 41.82% | 3.35 |
| Certara, Inc. (CERT) | 0.40% | $2.50B | 7.04% | 45.91% | 8.14 |
| Syndax Pharmaceuticals, Inc. (SNDX) | 0.40% | $2.09B | N/A | N/A | N/A |
| Elekta AB (EKTA.B) | 0.39% | $2.29B | 7.41% | 31.75% | 1.92 |
| Neuren Pharmaceuticals Ltd. (NEU) | 0.39% | $1.72B | 1,493.66% | N/A | 13.09 |
| Biohaven Ltd. (BHVN) | 0.38% | $3.55B | N/A | N/A | N/A |
| Zai Lab Ltd. (9688) | 0.37% | $1.84B | 38.46% | 61.42% | 3.15 |
| BioArctic AB (BRCTF) | 0.37% | $1.51B | -92.47% | 92.46% | 73.50 |
| Fortrea Holdings, Inc. (FTRE) | 0.36% | $2.41B | -13.36% | 12.99% | 1.72 |
| Kura Oncology, Inc. (KURA) | 0.36% | $1.58B | N/A | N/A | N/A |
| Tonghua Dongbao Pharmaceutical Co., Ltd. (600867) | 0.35% | $2.07B | -11.15% | 78.55% | 6.47 |
| Vera Therapeutics, Inc. (VERA) | 0.35% | $2.02B | N/A | N/A | N/A |
| Galapagos NV (GLPG) | 0.33% | $1.80B | -65.10% | 95.92% | -6.68 |
| Walvax Biotechnology Co., Ltd. (300142) | 0.33% | $2.42B | -27.51% | 80.94% | 6.07 |
| Structure Therapeutics, Inc. (GPCR) | 0.33% | $2.20B | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN) | 0.33% | $2.02B | -22.15% | 93.28% | 25.07 |
| Keros Therapeutics, Inc. (KROS) | 0.33% | $1.81B | N/A | -233.73% | 8,265.54 |
| Recursion Pharmaceuticals, Inc. (RXRX) | 0.32% | $2.10B | 13.68% | -5.60% | 45.52 |
| Vir Biotechnology, Inc. (VIR) | 0.32% | $1.45B | -10.45% | 91.88% | 4.13 |
| Iovance Biotherapeutics, Inc. (IOVA) | 0.31% | $2.64B | N/A | -1,653.15% | 1,929.39 |
| Dynavax Technologies Corp. (DVAX) | 0.31% | $1.50B | 8.24% | 78.41% | 4.86 |
| Betta Pharmaceuticals Co., Ltd. (300558) | 0.31% | $1.86B | 38.45% | 82.41% | 7.24 |
| Evotec SE (EVT) | 0.30% | $1.67B | N/A | 16.65% | 3.46 |
| Prothena Corp. Plc (PRTA) | 0.30% | $1.33B | -97.69% | -1,674.00% | 8.91 |
| Shenzhen Kangtai Biological Products Co., Ltd. (300601) | 0.30% | $1.78B | -39.68% | 83.97% | 8.29 |
| MiMedx Group, Inc. (MDXG) | 0.29% | $1.14B | 18.18% | 84.45% | 3.37 |
| Xencor, Inc. (XNCR) | 0.28% | $1.31B | -32.47% | 76.30% | 5.60 |
| GH Research Plc (GHRS) | 0.27% | $614.45M | N/A | N/A | N/A |
| CureVac NV (CVAC) | 0.27% | $816.47M | 75.57% | -269.85% | 6.25 |
| CanSino Biologics, Inc. (CASBF) | 0.27% | $683.59M | 8.16% | 58.84% | 4.68 |
| RemeGen Co., Ltd. (688331) | 0.25% | $1.57B | 96.12% | 77.19% | 24.34 |
| Simulations Plus, Inc. (SLP) | 0.25% | $790.11M | 14.23% | 71.49% | 12.95 |
| Chengdu Kanghua Biological Products Co., Ltd. (300841) | 0.25% | $933.20M | 11.90% | 95.83% | 4.11 |
| Jinyu Bio-Technology Co., Ltd. (600201) | 0.25% | $991.14M | -4.45% | 60.48% | 5.17 |
| Ironwood Pharmaceuticals, Inc. (IRWD) | 0.24% | $1.08B | -28.05% | 99.31% | 4.70 |
| Adaptive Biotechnologies Corp. (ADPT) | 0.23% | $638.10M | 11.23% | 50.35% | 2.22 |
| Bio-Thera Solutions, Ltd. (688177) | 0.21% | $1.14B | 4.39% | 69.69% | 21.16 |
| Mind Medicine (MindMed), Inc. (MNMD) | 0.20% | $678.95M | N/A | N/A | N/A |
| SAGE Therapeutics, Inc. (SAGE) | 0.19% | $630.11M | 139.89% | 83.94% | 4.52 |
| Annexon, Inc. (ANNX) | 0.19% | $650.93M | N/A | N/A | N/A |
| Organogenesis Holdings, Inc. (ORGO) | 0.19% | $426.88M | 2.17% | 70.58% | 0.92 |
| Revance Therapeutics, Inc. (RVNC) | 0.16% | $392.73M | 5.28% | 67.48% | 2.75 |
| CStone Pharmaceuticals Co. Ltd. (2616) | 0.15% | $192.31M | -8.44% | 61.50% | 4.17 |
| Adaptimmune Therapeutics Plc (ADAP) | 0.14% | $332.23M | -88.19% | 50.16% | 14.30 |
| Acumen Pharmaceuticals, Inc. (ABOS) | 0.12% | $204.87M | N/A | N/A | N/A |
| VistaGen Therapeutics, Inc. (VTGN) | 0.08% | $98.48M | N/A | 46.62% | -13.96 |
| JW (Cayman) Therapeutics Co. Ltd. (2126) | 0.08% | $95.71M | 13.38% | 7.69% | 0.90 |
| Relmada Therapeutics, Inc. (RLMD) | 0.08% | $122.21M | N/A | N/A | N/A |
| FibroGen, Inc. (FGEN) | 0.07% | $122.35M | 54.59% | 53.93% | 1.59 |
| Leap Therapeutics, Inc. (LPTX) | 0.06% | $83.03M | N/A | N/A | N/A |
| NRX Pharmaceuticals, Inc. (NRXP) | 0.03% | $25.04M | N/A | N/A | N/A |
| Bright Minds Biosciences, Inc. (DRUG) | 0.01% | $4.69M | N/A | N/A | N/A |
| FSD Pharma, Inc. (HUGE) | 0.01% | $5.71M | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB) | 0.01% | $3.75M | N/A | N/A | N/A |
| Seelos Therapeutics, Inc. (SEEL) | <0.01% | $1.35M | -28.34% | 97.41% | 10.28 |
Market data by FactSet
